Concepedia

Philip E.J. Sanderson

PE

Statistics

Publications

36

Citations

2.1K

H-Index

23

Active since

1987

Affiliations

United States Military Academy(Current)

National Center for Advancing Translational Sciences

National Institutes of Health

Merck & Co., Inc., Rahway, NJ, USA (United States)

Brigham and Women's Hospital

Philip E.J. Sanderson is an author at United States Military Academy specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

1987–2022

36

Publications

36

Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs

Jennifer Kouznetsova, Wei Sun, Carles Martínez‐Romero et al. · Emerging Microbes & Infections · 2014 · 241 citations · Full text

, , +12

The phenyldimethylsilyl group as a masked hydroxy group

Ian Fleming, Rolf Henning, David C. Parker et al. · Journal of the Chemical Society Perkin Transactions 1 · 1995 · 240 citations

, , +12

A one-pot conversion of the phenyldimethylsilyl group into a hydroxyl group

Ian Fleming, Philip E.J. Sanderson · Tetrahedron Letters · 1987 · 205 citations

, , +9

The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents

P.H. Hutson, Eleftheria N. Finger, Brian C. Magliaro et al. · Neuropharmacology · 2011 · 139 citations

, , +16

An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19

Jonathan H. Shrimp, Stephen C. Kales, Philip E.J. Sanderson et al. · ACS Pharmacology & Translational Science · 2020 · 133 citations · Full text

, , +17

1–5 of 36